Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2007

01.02.2007

Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging

verfasst von: Brian Hung-Hin Lang, MBBS, FRACS, Chung-Yau Lo, MS, FRCS (Edin), FACS, Wai-Fan Chan, MBBS, FRCS, King-Yin Lam, MD, FRCPA, Koon-Yat Wan, MBBS, FRCR

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) are two distinct histological types of thyroid carcinoma but have often been studied and staged as a collective group, known as differentiated thyroid carcinoma (DTC). However, this may not be an optimal approach to cancer staging.

Methods

A total of 760 patients with DTC, comprising 589 (77.5%) with PTC and 171 with (22.5%) FTC, being managed at our institution from 1961 to 2001 were retrospectively reviewed. Their clinicopathological features, treatment modalities received, and postoperative outcome were analyzed. Both univariate and multivariate analyses were performed to identify prognostic factors related to cancer-specific survival (CSS) for PTC and FTC.

Results

There were statistically significant differences between PTC and FTC in terms of age ≥50 years at diagnosis (P = .040), tumor size (P < .001), lymph node metastases (P < .001), distant metastases (P < .001), extrathyroidal extension (P < .001), multifocality (P = .002), capsular invasion (P < .001), extent of thyroid resection (P < .001), radioiodine ablation (P < .001), and external-beam irradiation (P = .003). Although PTC and FTC had similar 10-year and 15-year CSS (P = .846), each possessed its own set of independent prognostic factors for CSS. Age at diagnosis and completeness of resection were independent prognostic factors in both PTC and FTC.

Conclusions

There were marked differences in clinicopathologic features, treatment, and prognostic factors between the two histologic types of DTC. Different staging systems should be evaluated and validated for PTC and FTC individually in the future.
Literatur
3.
Zurück zum Zitat Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972–1995. Cancer Causes Control 2000;11:163–70PubMedCrossRef Haselkorn T, Bernstein L, Preston-Martin S, Cozen W, Mack WJ. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972–1995. Cancer Causes Control 2000;11:163–70PubMedCrossRef
4.
Zurück zum Zitat Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 2004;11:1093–7PubMedCrossRef Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 2004;11:1093–7PubMedCrossRef
5.
Zurück zum Zitat Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 2005;62:156–62CrossRef Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 2005;62:156–62CrossRef
6.
Zurück zum Zitat Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 2006;16:47–53PubMedCrossRef Burgess JR, Tucker P. Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 2006;16:47–53PubMedCrossRef
7.
Zurück zum Zitat Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447–62PubMedCrossRef Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447–62PubMedCrossRef
8.
Zurück zum Zitat Eustatia-Rutten CFA, Corssmit EPM, Biermasz NR, Pereira AM, Romijn JA, Smit JW. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91:313–9PubMedCrossRef Eustatia-Rutten CFA, Corssmit EPM, Biermasz NR, Pereira AM, Romijn JA, Smit JW. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91:313–9PubMedCrossRef
9.
Zurück zum Zitat Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033–41PubMed Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033–41PubMed
10.
Zurück zum Zitat Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088–95PubMed Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088–95PubMed
11.
Zurück zum Zitat Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947–53PubMed Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947–53PubMed
12.
Zurück zum Zitat DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metabol 1990:71:414–24CrossRef DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metabol 1990:71:414–24CrossRef
13.
Zurück zum Zitat Pasieka JL, Zedenius J, Auer G, et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid carcinoma. Surgery 1992;112:1154–60PubMed Pasieka JL, Zedenius J, Auer G, et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid carcinoma. Surgery 1992;112:1154–60PubMed
14.
Zurück zum Zitat Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050–8PubMed Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050–8PubMed
15.
Zurück zum Zitat Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418–28PubMedCrossRef Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418–28PubMedCrossRef
16.
Zurück zum Zitat Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 1993;72:2680–5PubMedCrossRef Akslen LA. Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 1993;72:2680–5PubMedCrossRef
17.
Zurück zum Zitat Noguchi S, Murakami N, Kawamoto H. Classification of papillary cancer of the thyroid based on prognosis. World J Surg 1994;18:552–8PubMedCrossRef Noguchi S, Murakami N, Kawamoto H. Classification of papillary cancer of the thyroid based on prognosis. World J Surg 1994;18:552–8PubMedCrossRef
18.
Zurück zum Zitat Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of the thyroid. Surgery 1994;116:1036–41PubMed Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of the thyroid. Surgery 1994;116:1036–41PubMed
19.
Zurück zum Zitat Lerch H, Schober O, Kuwert T, Saur HB. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 1997;15:2067–75PubMed Lerch H, Schober O, Kuwert T, Saur HB. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 1997;15:2067–75PubMed
20.
Zurück zum Zitat Sherman SI, Brierley JD, Sperling M, et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. Cancer 1998;83:1012–21PubMedCrossRef Sherman SI, Brierley JD, Sperling M, et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. Cancer 1998;83:1012–21PubMedCrossRef
21.
Zurück zum Zitat Beeken S, Roye D, Weiss H, et al. Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg 2000;179:51–6CrossRef Beeken S, Roye D, Weiss H, et al. Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg 2000;179:51–6CrossRef
22.
Zurück zum Zitat Ortiz Sebastian S, Rodriguez Gonzalez M, Parilla Paricio P, et al. Papillary thyroid carcinoma. Prognostic index for survival including the histological variety. Arch Surg 2000;135:272–7CrossRef Ortiz Sebastian S, Rodriguez Gonzalez M, Parilla Paricio P, et al. Papillary thyroid carcinoma. Prognostic index for survival including the histological variety. Arch Surg 2000;135:272–7CrossRef
23.
Zurück zum Zitat Sobin LH, Wittekind CH. (2002) TNM Classification of Malignant Tumors. 6th ed. New York: Wiley-Liss. Sobin LH, Wittekind CH. (2002) TNM Classification of Malignant Tumors. 6th ed. New York: Wiley-Liss.
24.
Zurück zum Zitat Greene FL, Balch CM, Fleming ID, Fritz AG, Page DL. (2003) AJCC Cancer Staging Handbook. 6th ed. New York: Springer-Verlag. Greene FL, Balch CM, Fleming ID, Fritz AG, Page DL. (2003) AJCC Cancer Staging Handbook. 6th ed. New York: Springer-Verlag.
25.
Zurück zum Zitat Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135:139–48PubMedCrossRef Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135:139–48PubMedCrossRef
26.
Zurück zum Zitat Yildrim E. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. J Am Coll Surg 2005;200:378–92CrossRef Yildrim E. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. J Am Coll Surg 2005;200:378–92CrossRef
27.
Zurück zum Zitat Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O’Sullivan B. A comparison of different staging systems. Predictability of patient outcome. Thyroid carcinoma as an example. Cancer 1997;79:2414–23PubMedCrossRef Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O’Sullivan B. A comparison of different staging systems. Predictability of patient outcome. Thyroid carcinoma as an example. Cancer 1997;79:2414–23PubMedCrossRef
28.
Zurück zum Zitat Passler C, Prager G, Scheuba C, Kaserer K, Zettinig G, Niederle B. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg 2003;207:227–34CrossRef Passler C, Prager G, Scheuba C, Kaserer K, Zettinig G, Niederle B. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg 2003;207:227–34CrossRef
29.
Zurück zum Zitat D’Avanzo A, Ituarte P, Treseler P, et al. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 2004;14:453–8PubMedCrossRef D’Avanzo A, Ituarte P, Treseler P, et al. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 2004;14:453–8PubMedCrossRef
30.
Zurück zum Zitat Lo CY, Chan WF, Kam KY, Wan KY. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 2005;242:708–15PubMedCrossRef Lo CY, Chan WF, Kam KY, Wan KY. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 2005;242:708–15PubMedCrossRef
31.
Zurück zum Zitat DeLellis RA, Lloyd RV, Heitz PU, Eng C. (2004) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press DeLellis RA, Lloyd RV, Heitz PU, Eng C. (2004) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press
32.
Zurück zum Zitat Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794–804PubMedCrossRef Tubiana M, Schlumberger M, Rougier P, et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794–804PubMedCrossRef
33.
Zurück zum Zitat Lerch H, Schober O, Kuwert T, Saur HB. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 1997;15:2067–75PubMed Lerch H, Schober O, Kuwert T, Saur HB. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 1997;15:2067–75PubMed
34.
Zurück zum Zitat Steinmuller T, Klupp J, Rayes N, et al. Prognostic factors in patients with thyroid carcinoma. Eur J Surg 2000;166:29–33PubMedCrossRef Steinmuller T, Klupp J, Rayes N, et al. Prognostic factors in patients with thyroid carcinoma. Eur J Surg 2000;166:29–33PubMedCrossRef
35.
Zurück zum Zitat Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary thyroid and follicular thyroid cancer. Am J Med 1994;97:418–28PubMedCrossRef Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary thyroid and follicular thyroid cancer. Am J Med 1994;97:418–28PubMedCrossRef
36.
Zurück zum Zitat Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer 2000;89:202–17PubMedCrossRef Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer 2000;89:202–17PubMedCrossRef
37.
Zurück zum Zitat Holzer S, Reiners C, Mann K, et al. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. US and German Thyroid Cancer Group. Cancer 2000;89:192–201PubMedCrossRef Holzer S, Reiners C, Mann K, et al. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. US and German Thyroid Cancer Group. Cancer 2000;89:192–201PubMedCrossRef
38.
Zurück zum Zitat Chow SM, Law SC, Au SK, et al. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head Neck 2002;24:670–7PubMedCrossRef Chow SM, Law SC, Au SK, et al. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head Neck 2002;24:670–7PubMedCrossRef
39.
Zurück zum Zitat Machens A, Holzhausen H-J, Dralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 2005;103:2269–73PubMedCrossRef Machens A, Holzhausen H-J, Dralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 2005;103:2269–73PubMedCrossRef
40.
Zurück zum Zitat LiVolvsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases and experiences. Adv Anat Pathol 2004;11:279–87CrossRef LiVolvsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases and experiences. Adv Anat Pathol 2004;11:279–87CrossRef
41.
Zurück zum Zitat Zeiger MA, Dackiw APB. Follicular thyroid lesions, elements that affect both diagnosis and prognosis. J Surg Oncol 2005;89:108–13PubMedCrossRef Zeiger MA, Dackiw APB. Follicular thyroid lesions, elements that affect both diagnosis and prognosis. J Surg Oncol 2005;89:108–13PubMedCrossRef
42.
Zurück zum Zitat Passler C, Scheuba C, Prager G, et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 2004;11:131–9PubMedCrossRef Passler C, Scheuba C, Prager G, et al. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 2004;11:131–9PubMedCrossRef
43.
Zurück zum Zitat Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004;11:571–9PubMedCrossRef Jukkola A, Bloigu R, Ebeling T, Salmela P, Blanco G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004;11:571–9PubMedCrossRef
44.
Zurück zum Zitat Besic N, Zgajnar J, Hocevar M, Frkovic-Grazio S. Is patient’s age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid 2005;15:439–48PubMedCrossRef Besic N, Zgajnar J, Hocevar M, Frkovic-Grazio S. Is patient’s age a prognostic factor for follicular thyroid carcinoma in the TNM classification system? Thyroid 2005;15:439–48PubMedCrossRef
45.
Zurück zum Zitat Chow SM, Law SC, Mendenhall WM, et al. Follicular thyroid carcinoma: prognostic factors and the role of iodine. Cancer 2002;95:488–98PubMedCrossRef Chow SM, Law SC, Mendenhall WM, et al. Follicular thyroid carcinoma: prognostic factors and the role of iodine. Cancer 2002;95:488–98PubMedCrossRef
46.
Zurück zum Zitat Witte J, Goretzki PE, Dieken J, Simon D, Roher HD. Importance of lymph node metastases in follicular thyroid cancer. World J Surg 2002;26:1017–22PubMedCrossRef Witte J, Goretzki PE, Dieken J, Simon D, Roher HD. Importance of lymph node metastases in follicular thyroid cancer. World J Surg 2002;26:1017–22PubMedCrossRef
47.
Zurück zum Zitat Sherman SI. Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma. Semin Surg Oncol 1999;16:12–5PubMedCrossRef Sherman SI. Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma. Semin Surg Oncol 1999;16:12–5PubMedCrossRef
Metadaten
Titel
Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging
verfasst von
Brian Hung-Hin Lang, MBBS, FRACS
Chung-Yau Lo, MS, FRCS (Edin), FACS
Wai-Fan Chan, MBBS, FRCS
King-Yin Lam, MD, FRCPA
Koon-Yat Wan, MBBS, FRCR
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2007
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9207-5

Weitere Artikel der Ausgabe 2/2007

Annals of Surgical Oncology 2/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.